邻苯二酚-O-甲基转移酶
核糖
化学
儿茶酚
甲基转移酶
脱氧核糖
酶
生物化学
多巴胺
立体化学
生物
神经科学
DNA
等位基因
甲基化
基因
作者
Manuel Ellermann,C. Lerner,Guillaume Burgy,A. Ehler,Caterina Bissantz,Roland Jakob-Rœtne,Ralph Paulini,Oliver Allemann,Héloïse Tissot,Dan Grünstein,M. Stihle,François Diederich,M.G. Rudolph
标识
DOI:10.1107/s0907444912001138
摘要
The biological activity of catechol neurotransmitters such as dopamine in the synapse is modulated by transporters and enzymes. Catechol-O-methyltransferase (COMT; EC 2.1.1.6) inactivates neurotransmitters by catalyzing the transfer of a methyl group from S-adenosylmethionine to catechols in the presence of Mg2+. This pathway also inactivates l-DOPA, the standard therapeutic for Parkinson's disease. Depletion of catechol neurotransmitters in the prefrontal cortex has been linked to schizophrenia. The inhibition of COMT therefore promises improvements in the treatment of these diseases. The concept of bisubstrate inhibitors for COMT has been described previously. Here, ribose-modified bisubstrate inhibitors were studied. Three high-resolution crystal structures of COMT in complex with novel ribose-modified bisubstrate inhibitors confirmed the predicted binding mode but displayed subtle alterations at the ribose-binding site. The high affinity of the inhibitors can be convincingly rationalized from the structures, which document the possibility of removing and/or replacing the ribose 3′-hydroxyl group and provide a framework for further inhibitor design.
科研通智能强力驱动
Strongly Powered by AbleSci AI